Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Weissinger, Eva M  [Clear All Filters]
2013
Bunse CE, Borchers S, Varanasi PR, Tischer S, Figueiredo C, Immenschuh S, Kalinke U, Köhl U, Goudeva L, Maecker-Kolhoff B, et al. Impaired Functionality of Antiviral T Cells in G-CSF Mobilized Stem Cell Donors: Implications for the Selection of CTL Donor. PLoS One. 2013;8(12):e77925.
2015
van der Torren CR, van Hensbergen Y, Luther S, Aghai Z, Rychnavská ZStachová, Slot M, Scherjon S, Kröger N, Ganser A, Weissinger EM, et al. Possible Role of Minor H Antigens in the Persistence of Donor Chimerism after Stem Cell Transplantation; Relevance for Sustained Leukemia Remission. PLoS One. 2015;10(3):e0119595.
2019
Varanasi PReddy, Ogonek J, Luther S, Dammann E, Stadler M, Ganser A, Borchers S, Hambach L, Weissinger EM. Cytomegalovirus-specific CD8+ T-cells are associated with a reduced incidence of early relapse after allogeneic stem cell transplantation. PLoS One. 2019;14(3):e0213739.
2022
Osanyinlusi SA, Zischke J, Jacobs R, Weissinger EM, Schulz TF, Kay-Fedorov PC. Human Cytomegalovirus pUL11, a CD45 Ligand, Disrupts CD4 T Cell Control of Viral Spread in Epithelial Cells. mBio. 2022:e0294622.
2023
Stadler M, Hambach L, Dammann E, Diedrich H, Kamal H, Hamwi I, Schultze-Florey C, Varvenne M, Ehrlich S, Buchholz S, et al. The graft-versus-leukemia effect of prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation is equally effective in relapse prevention but safer compared to spontaneous graft-versus-host disease. Ann Hematol. 2023.